Inhaled corticosteroids in COPD: the case against

Suissa S. , Barnes P. J.

Source: Eur Respir J 2009; 34: 13-16

Journal Issue: July

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Suissa S. , Barnes P. J.. Inhaled corticosteroids in COPD: the case against. Eur Respir J 2009; 34: 13-16

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Inhaled corticosteroids in COPD: a case in favour Source: Eur Respir J 2009; 34: 10-12 Year: 2009
Inhaled steroids and COPD Source: Eur Respir J 2008; 32: 523-524 Year: 2008
Inhaled corticosteroids in COPD: the clinical evidence Source: Eur Respir J 2015; 45: 525-537 Year: 2015
Inhaled steroids in exacerbations of COPD Source: Eur Respir J 2007; 30: 398 Year: 2007
Inhaled corticosteroids: a controversial add-on treatment in COPD Source: Eur Respir J 2010; 36: 973-974 Year: 2010
Inhaled corticosteroids in the treatment of acute asthma Source: Eur Respir J 2002; 20: Suppl. 38, 305s Year: 2002
What to use INSTEAD of inhaled corticosteroids in COPD? Source: Eur Respir J 2014; 44: 1391-1393 Year: 2014
Weaning from inhaled corticosteroids in COPD: the evidence Source: Eur Respir J 2015; 46: 1232-1235 Year: 2015
Inhaled corticosteroids as a cause of CAP Source: Eur Respir Monogr 2014; 63: 234-242 Year: 2014
Inhaled beta2-agonists in asthma management: an evolving story Source: Breathe 2016; 12: 375-377 Year: 2016
Inhaled corticosteroids in COPD: the final verdict is… Source: Eur Respir J, 52 (6) 1801940; 10.1183/13993003.01940-2018 Year: 2018
Cough variant asthma treated with bronchodilators, without inhaled corticosteroids Source: Annual Congress 2009 - From cough to sound analysis of breathing Year: 2009
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience Source: ERJ Open Res, 8 (1) 00014-2022; 10.1183/23120541.00014-2022 Year: 2022
Inhaled corticosteroid containing combinations and mortality in COPD Source: Eur Respir J, 52 (6) 1801230; 10.1183/13993003.01230-2018 Year: 2018
Exacerbations and inhaled corticosteroids in bronchiectasis patients Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
Role of tiotropium in reducing exacerbations in COPD patients when added to long-acting beta2-agonists (LABA) and inhaled corticosteroids (ICS): The OUTPUL study Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease Year: 2013
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901035; 10.1183/13993003.01035-2019 Year: 2019
Inhaled corticosteroids and pneumonia mortality in COPD patients Source: Eur Respir J, 54 (3) 1901276; 10.1183/13993003.01276-2019 Year: 2019
Inhaled corticosteroids and the risk of a first exacerbation in COPD patients Source: Eur Respir J 2004; 23: 692-697 Year: 2004
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results Source: Eur Respir J 2009; 34: 641 Year: 2009